Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

First Takes

CMS and FDA Align on New Approaches to Drive Digital Health Adoption

The two agencies are launching allied programs next year to jumpstart market access for digital tools addressing chronic conditions. The nascent CMS ACCESS Model seeks to bypass Medicare barriers for digital health by offering outcome-aligned payments to technology-oriented clinics and companies. Meanwhile, FDA’s TEMPO pilot will grant regulatory enforcement discretion to some technologies used in the Medicare model. But implementation questions remain.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Regulatory & Reimbursement

Sitting Ducks: The State of Medical Device Cybersecurity

As connectivity in medical devices may be outpacing manufacturers’ ability to keep them safe from interference by skilled cyber-attackers, a tech policy expert shares his suggestions for makers and regulators to ensure the highest degree of digital protection.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More